Laboratory Research on AOD-9604 AOD-9604 is primarily studied in preclinical models to investigate fat metabolism
Both peptides produce gastrointestinal adverse events during titration: cagrilintide causes nausea in 42% of participants, while survodutide reports nausea in 38%, diarrhoea in 24%, and vomiting in 18%
Access this article Similar content being viewed by others Data availability The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request
Although renal function as assessed by serum values of creatinine and urea was not improved (Fig
Also, by preventing oxidative stress, glutathione can reduce visible signs of aging, like wrinkles, and improve skin elasticity
That said, AOD9604 is believed to emulate hGHs fat-burning potential on targets like hormone-sensitive lipase (HSL) and acetyl-CoA carboxylase (ACC) without significantly altering carbohydrate metabolism or stimulating IGF-1 production